Cacaoidin, first member of the new lanthidin RiPP family FJ Ortiz‐López, D Carretero‐Molina, M Sánchez‐Hidalgo, J Martín, ... Angewandte Chemie International Edition 59 (31), 12654-12658, 2020 | 87 | 2020 |
Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection M Ponce-Alonso, JS de la Fuente, A Rincón-Carlavilla, P Moreno-Nunez, ... Infection Control & Hospital Epidemiology 42 (4), 406-410, 2021 | 86 | 2021 |
Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two … S Garcia-Fernandez, MI Morosini, F Marco, D Gijon, A Vergara, J Vila, ... Journal of Antimicrobial Chemotherapy 70 (4), 1047-1050, 2015 | 68 | 2015 |
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: the SUPERIOR multicentre study S García-Fernández, M García-Castillo, G Bou, J Calvo, E Cercenado, ... International journal of antimicrobial agents 53 (5), 682-688, 2019 | 45 | 2019 |
Gut eradication of VIM-1 producing ST9 Klebsiella oxytoca after fecal microbiota transplantation for diarrhea caused by a Clostridium difficile hypervirulent R027 strain S García-Fernández, MI Morosini, M Cobo, JR Foruny, ... Diagnostic microbiology and infectious disease 86 (4), 470-471, 2016 | 39 | 2016 |
Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario S García-Fernández, M Frentrup, M Steglich, A Gonzaga, M Cobo, ... Scientific reports 9 (1), 6959, 2019 | 37 | 2019 |
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation … M García-Castillo, S García-Fernández, R Gómez-Gil, C Pitart, M Oviaño, ... International journal of antimicrobial agents 51 (3), 511-515, 2018 | 33 | 2018 |
Detection of carbapenemase production in a collection of Enterobacteriaceae with characterized resistance mechanisms from clinical and environmental origins by use of both … S García-Fernández, MI Morosini, D Gijón, L Beatobe, P Ruiz-Garbajosa, ... Journal of Clinical Microbiology 54 (2), 464-466, 2016 | 29 | 2016 |
A publicly accessible database for Clostridioides difficile genome sequences supports tracing of transmission chains and epidemics M Frentrup, Z Zhou, M Steglich, JP Meier-Kolthoff, M Göker, T Riedel, ... Microbial Genomics 6 (8), e000410, 2020 | 27 | 2020 |
Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates A Vergara, Y Zboromyrska, N Mosqueda, MI Morosini, ... Antimicrobial Agents and Chemotherapy 58 (12), 7538-7540, 2014 | 25 | 2014 |
Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales S García-Fernández, M García-Castillo, P Ruiz-Garbajosa, MI Morosini, ... Diagnostic Microbiology and Infectious Disease 93 (1), 1-4, 2019 | 22 | 2019 |
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in … S García-Fernández, M García-Castillo, J Melo-Cristino, MF Pinto, ... International journal of antimicrobial agents 55 (3), 105887, 2020 | 20 | 2020 |
CHROMagar mSuperCARBA performance in carbapenem-resistant Enterobacteriaceae isolates characterized at molecular level and routine surveillance rectal swab specimens S García-Fernández, M Hernández-García, A Valverde, P Ruiz-Garbajosa, ... Diagnostic Microbiology and Infectious Disease 87 (3), 207-209, 2017 | 20 | 2017 |
Multicenter evaluation of the new Etest gradient diffusion method for piperacillin-tazobactam susceptibility testing of Enterobacterales, Pseudomonas aeruginosa, and … S García-Fernández, Y Bala, T Armstrong, M García-Castillo, ... Journal of clinical microbiology 58 (2), 10.1128/jcm. 01042-19, 2020 | 19 | 2020 |
Confronting ceftolozane-tazobactam susceptibility in multidrug-resistant Enterobacterales isolates and whole-genome sequencing results (STEP study) M Hernández-García, S García-Fernández, M García-Castillo, ... International journal of antimicrobial agents 57 (2), 106259, 2021 | 17 | 2021 |
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection R Escudero-Sánchez, M Ruiz-Ruigómez, J Fernández-Fradejas, ... Journal of Clinical Medicine 10 (1), 2, 2020 | 17 | 2020 |
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain … M Hernández-García, M García-Castillo, S García-Fernández, ... Journal of Antimicrobial Chemotherapy 76 (2), 370-379, 2021 | 16 | 2021 |
Presence of Chromosomal crpP-like Genes Is Not Always Associated with Ciprofloxacin Resistance in Pseudomonas aeruginosa Clinical Isolates Recovered in … M Hernández-García, M García-Castillo, S García-Fernández, ... Microorganisms 9 (2), 388, 2021 | 12 | 2021 |
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain M Hernández-García, S García-Fernández, M García-Castillo, G Bou, ... JAC-Antimicrobial Resistance 2 (4), dlaa084, 2020 | 10 | 2020 |
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP … M Hernández-García, M García-Castillo, J Melo-Cristino, MF Pinto, ... Journal of Antimicrobial Chemotherapy 77 (11), 3163-3172, 2022 | 9 | 2022 |